| abstract |
The present invention provides a pharmaceutical composition comprising at least one PI3K inhibitor of formula I or a pharmaceutically acceptable salt thereof and at least one HDAC inhibitor such as a compound of formula II or a pharmaceutically acceptable salt thereof; Or at least one PI3K inhibitor, such as a compound of formula I, or a pharmaceutically acceptable salt thereof, and at least one HDAC inhibitor of formula (II) or a pharmaceutically acceptable salt thereof. |